CPT1A and breast carcinoma: In contrast, the FASN inhibitor cerulenin reduced CPT1A expression only in NFYA wild-type cells, suggesting that NFYA regulates breast cancer malignant behavior by controlling de novo lipogenesis by regulating ACACA and FASN expression.